NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / *W EXP 02/10/202
Number of holders
28
Total 13F shares, excl. options
4,159,614
Shares change
+4,113,060
Total reported value, excl. options
$11,088,000
Value change
+$10,964,000
Number of buys
27
Price
$2.67

Significant Holders of NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS) as of Q1 2021

29 filings reported holding NUVBWS - NUVATION BIO INC - *W EXP 02/10/202 as of Q1 2021.
NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,159,614 shares .
Largest 10 shareholders include 683 Capital Management, LLC (825,323 shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (383,825 shares), BOXER CAPITAL, LLC (266,666 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (266,666 shares), FRANKLIN RESOURCES INC (266,666 shares), BlackRock Inc. (233,331 shares), WELLINGTON MANAGEMENT GROUP LLP (229,835 shares), Castle Creek Arbitrage, LLC (215,426 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (166,666 shares), and Walleye Capital LLC (163,105 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.